A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle

Pharmaceutical Research

Volumn 16, Issue 5, 1999, Pages 682-688

  Tobío, María ^a   Nolley, Jessica ^a   Guo, Yuyi ^b   McIver, James ^b   Alonso, María José ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Massachusetts Biologic Laboratories   (United States)

Author keywords

Immune response; Poloxamer PLGA microspheres; Tetanus toxoid; Vaccine delivery

Indexed keywords

DRUG VEHICLE; MICROSPHERE; POLOXAMER; POLYGLACTIN; RESOMER; RG 506; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG ISOLATION; DRUG RELEASE; FEMALE; IMMUNIZATION; INFRARED SPECTROSCOPY; MICROENCAPSULATION; MISCIBILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIGENS; BIOCOMPATIBLE MATERIALS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HYDROGEN BONDING; IMMUNIZATION; IMMUNOGLOBULIN G; LACTIC ACID; MICE; MICROSCOPY, ELECTRON, SCANNING; NEUTRALIZATION TESTS; OILS; PARTICLE SIZE; POLOXAMER; POLYGLYCOLIC ACID; POLYMERS; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TETANUS TOXOID;

EID: 0032956055     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018820507379     Document Type: Article

References (24)

1. 1. I. Esparza, and T. Kissel. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine 10:714-720 (1992).
2. 2. B. Gander, C. Thomasin, H. P. Merkle, Y. Men, and G. Corradin. Pulsed tetanus toxoid release from PLGA-microspheres and its relevance for immunogenicity in mice. Proceed. Intern. Symp. Ret. Bioact. Mater. 20:65-66 (1993).
3. 3. M. J. Alonso, R. K. Gupta, C. Min, G. R. Siber, and R. Langer. Biodegradable microspheres as controlled release tetanus toxoid delivery systems. Vaccine 2:299-306 (1994).
4. 4. M. J. Alonso, S. Cohen, T. G. Park, R. K. Gupta, G. R. Siber, and R. Langer. Determinants of release of tetanus vaccine from polyester microspheres. Pharm. Res. 10:945-953 (1993).
5. 5. Y. Men, C. Thomasin, H. P. Merkle, B. Gander, and G. Corradin. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. Vaccine 13:683-689 (1995).
6. 6. C. Thomasin, G. Corradin, Y. Men, H. P. Merkle, and B. Gander. Tetanus toxoid and synthetic malaria antigen containing poly(laclide)/poly(lactide-coglycolide)-microspheres: importance of polymer degradation and antigen release for immune response. J. Contr. Rel. 41:131-145 (1996).
7. 7. R. K. Gupta, J. Alroy, M. J. Alonso, R. Langer, and G. R. Siber. Chronic local tissue reactions, long term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers. Vaccine 15:1716-1723 (1997).
8. 8. S. P. Schwendeman, M. Cardamone, M. Branden, A. Klibanov, and R. Langer. Stability of proteins and their delivery from biodegradable polymer microspheres. In S. Cohen and H. Bernstein (eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996, pp. 1-50.
9. 9. M. Tobío, and M. J. Alonso. Study of the inactivation process of tetanus toxoid in the presence of PLGA degrading microspheres. S.T. P. Pharma. Sci. 8:303-310 (1998).
10. 10. A. C. Chang, and R. K. Gupta. Stabilization of tetanus toxoid in poly(D,L-lactic-co-glycolic acid) microspheres for the controlled release of antigen. J. Pharm. Sci. 85:129-132 (1996).
11. 11. S. P. Schwendeman, H. R. Constantino, R. K. Gupta, M. Tobío, A. C. Chang, M. J. Alonso, G. R. Siber, and R. Langer. Strategies for stabilizing tetanus toxoid towards the development of a single-dose tetanus vaccine. In F. Brown (ed.), Developments in Biological Standardization: New Approaches to Stabilization of Vaccine Potency, WHO Series, 1996, pp. 293-306.
12. 12. R. Wada, S. H. Hyon, and Y. Ykada. Lactic acid oligomer microspheres containing hydrophilic drugs. J. Pharm. Sci. 79:919-924 (1990).
13. 13. E. H. Relyveld. Titrage in vivo des anticorps antidiphteriques et antitetaniques à plusiers niveaux. J Biol. Stand. 5:45-55 (1977).
14. 14. R. K. Gupta, S. C. Maheshwari, and H. Singh. The titration of tetanus antitoxin. Studies of the sensitivity and reproducibility of the toxin neutralization test. J. Biol. Stand. 13:143-149 (1985).
15. 15. M. J. Alonso, B. Villamayor, M. Tobío, S. Schwendeman, R. K. Gupta, G. R. Siber, and R. Langer. Innovative approaches for the stabilization and controlled release of tetanus vaccine from polyester microspheres. Proceed. Intern. Symp. Rel. Bioact. Mater. 23:825-826 (1996).
16. 16. T. K. Law, T. L. Whateley, and A. T. Florence. Stabilization of w/o/w multiple emulsions by interfacial complexation of macromolecules and nonionic surfactants. J. Contr. Rel. 3:279-290 (1986).
17. 17. N. Nihant, C. Schugens, C. Grandfills, R. Jérome, and Ph. Teyssié. Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability. Pharm. Res. 11:1479-1484 (1994).
18. 18. Ch. Schugens, N. Laruelle, N. Nihant, Ch. Grandfils, R. Jérome, and Ph. Teyssié. Effect of the emulsion stability on the morphology and porosity of semicrystalline poly l-lactide microparticles prepared by w/o/w double emulsion-evaporation. J. Contr. Rel. 32:161-176 (1994).
19. 19. A. Zaks, and A. M. Klibanov. The effect of water on enzyme action in organic media. J. Biol. Chem. 263:8017-8021 (1988).
20. 20. M. J. Hageman. Water sorption and solid-state stability of proteins. In T. J. Ahern, and M. C. Manning (eds.), Stability of Protein Pharmaceuticals. Part A. Chemical and Physical Pathways of Protein Degradation. Plenum Press, New York, 1992, pp. 273-309.
21. 21. T. G. Park, S. Cohen, and R. Langer. Poly(L-lactic)/Pluronics blends: Characterization of phase separation behaviour, degradation, and morphology and use as protein-releasing matrices. Macromolecules 25:116-122 (1992).
22. 22. S. Cohen, T. Yoshioka, M. Lucarelli, L. H. Hwang, and R. Langer. Controlled delivery systems for protein based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8:713-720 (1991).
23. 23. H. T. Wang, E. Schmitt, D. R. Flanagan, and R. J. Linhardt. Influence of formulations methods on the in vitro controlled release of protein from poly(ester) microspheres. J. Contr. Rel. 17:23-32 (1991).
24. 24. R. K. Gupta, B. E. Rost, R. Relyveld, and G. R. Siber. Adjuvant properties of aluminum and calcium compounds. In M. F. Powell, and M. J. Newman (eds.), Vaccine Design: The Subunit and Adjuvant Approach, Plenum Press, New York, 1995, pp. 229-248.